Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy

Adult zebrafish is an emerging vertebrate model for studying genetic basis of cardiomyopathies; but whether the simple fish heart can model essential features of hypertrophic cardiomyopathy (HCM) remained unknown. Here, we report a comprehensive phenotyping of a lamp2 knockout (KO) mutant. LAMP2 enc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular and cellular cardiology 2019-08, Vol.133, p.199-208
Hauptverfasser: Dvornikov, Alexey V., Wang, Mingmin, Yang, Jingchun, Zhu, Ping, Le, Tai, Lin, Xueying, Cao, Hung, Xu, Xiaolei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 208
container_issue
container_start_page 199
container_title Journal of molecular and cellular cardiology
container_volume 133
creator Dvornikov, Alexey V.
Wang, Mingmin
Yang, Jingchun
Zhu, Ping
Le, Tai
Lin, Xueying
Cao, Hung
Xu, Xiaolei
description Adult zebrafish is an emerging vertebrate model for studying genetic basis of cardiomyopathies; but whether the simple fish heart can model essential features of hypertrophic cardiomyopathy (HCM) remained unknown. Here, we report a comprehensive phenotyping of a lamp2 knockout (KO) mutant. LAMP2 encodes a lysosomal protein and is a causative gene of Danon disease that is characterized by HCM and massive autophagic vacuoles accumulation in the tissues. There is no effective therapy yet to treat this most lethal cardiomyopathy in the young. First, we did find the autophagic vacuoles accumulation in cardiac tissues from lamp2 KO. Next, through employing a set of emerging phenotyping tools, we revealed heart failure phenotypes in the lamp2 KO mutants, including decreased ventricular ejection fraction, reduced physical exercise capacity, blunted β-adrenergic contractile response, and enlarged atrium. We also noted changes of the following indices suggesting cardiac hypertrophic remodeling in lamp2 KO: a rounded heart shape, increased end-systolic ventricular volume and density of ventricular myocardium, elevated actomyosin activation kinetics together with increased maximal isometric tension at the level of cardiac myofibrils. Lastly, we assessed the function of lysosomal-localized mTOR on the lamp2-associated Danon disease. We found that haploinsufficiency of mtor was able to normalize some characteristics of the lamp2 KO, including ejection fraction, β-adrenergic response, and the actomyosin activation kinetics. In summary, we demonstrate the feasibility of modeling the inherited HCM in the adult zebrafish, which can be used to develop potential therapies. [Display omitted] •Zebrafish has a single LAMP2 homologue.•Loss-of-function of lamp2 in zebrafish models human Danon disease•Both metabolic abnormality and cardiac dysfunction are recapitulated.•mtor inhibition attenuates cardiac dysfunction while metabolic abnormality persists.
doi_str_mv 10.1016/j.yjmcc.2019.06.013
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6705397</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022282819301348</els_id><sourcerecordid>2245641678</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-a06eb26857f1a4755bee36989642516e2555a27e096919a695a6d7e096436a13</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxS0EokvhEyAhH7kk2E7sxAeQUMU_qVIR2rs1sSeNlyQOtrdS-ulJu6WCC6fRaN57M5ofIa85Kznj6t2hXA-TtaVgXJdMlYxXT8iOMy2LVrb1U7JjTIhCtKI9Iy9SOjDGdF1Vz8lZxYVoJW935Of3AeeQ18XP1xRmCu44ZnqLXYTep4GOMC2CWojOh2kNC-RhpVNwOFLvcM6-95jotL_6Qf08-M5nH7aURGEzzc47yEjzgBGW9SV51sOY8NVDPSf7z5_2F1-Ly6sv3y4-Xha2ljoXwBR2QrWy6TnUjZQdYqV0q1UtJFcopJQgGmRaaa5BaQnK3bd1pYBX5-TDKXY5dhM6u10ZYTRL9BPE1QTw5t_J7AdzHW6MapisdLMFvH0IiOHXEVM2k08WxxFmDMdkhKilqrlq2k1anaQ2hpQi9o9rODN3lMzB3FMyd5QMU2ajtLne_H3ho-cPlk3w_iTA7U03HqNJ1uNs0fmINhsX_H8X_AaeK6YW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2245641678</pqid></control><display><type>article</type><title>Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Dvornikov, Alexey V. ; Wang, Mingmin ; Yang, Jingchun ; Zhu, Ping ; Le, Tai ; Lin, Xueying ; Cao, Hung ; Xu, Xiaolei</creator><creatorcontrib>Dvornikov, Alexey V. ; Wang, Mingmin ; Yang, Jingchun ; Zhu, Ping ; Le, Tai ; Lin, Xueying ; Cao, Hung ; Xu, Xiaolei</creatorcontrib><description>Adult zebrafish is an emerging vertebrate model for studying genetic basis of cardiomyopathies; but whether the simple fish heart can model essential features of hypertrophic cardiomyopathy (HCM) remained unknown. Here, we report a comprehensive phenotyping of a lamp2 knockout (KO) mutant. LAMP2 encodes a lysosomal protein and is a causative gene of Danon disease that is characterized by HCM and massive autophagic vacuoles accumulation in the tissues. There is no effective therapy yet to treat this most lethal cardiomyopathy in the young. First, we did find the autophagic vacuoles accumulation in cardiac tissues from lamp2 KO. Next, through employing a set of emerging phenotyping tools, we revealed heart failure phenotypes in the lamp2 KO mutants, including decreased ventricular ejection fraction, reduced physical exercise capacity, blunted β-adrenergic contractile response, and enlarged atrium. We also noted changes of the following indices suggesting cardiac hypertrophic remodeling in lamp2 KO: a rounded heart shape, increased end-systolic ventricular volume and density of ventricular myocardium, elevated actomyosin activation kinetics together with increased maximal isometric tension at the level of cardiac myofibrils. Lastly, we assessed the function of lysosomal-localized mTOR on the lamp2-associated Danon disease. We found that haploinsufficiency of mtor was able to normalize some characteristics of the lamp2 KO, including ejection fraction, β-adrenergic response, and the actomyosin activation kinetics. In summary, we demonstrate the feasibility of modeling the inherited HCM in the adult zebrafish, which can be used to develop potential therapies. [Display omitted] •Zebrafish has a single LAMP2 homologue.•Loss-of-function of lamp2 in zebrafish models human Danon disease•Both metabolic abnormality and cardiac dysfunction are recapitulated.•mtor inhibition attenuates cardiac dysfunction while metabolic abnormality persists.</description><identifier>ISSN: 0022-2828</identifier><identifier>EISSN: 1095-8584</identifier><identifier>DOI: 10.1016/j.yjmcc.2019.06.013</identifier><identifier>PMID: 31228518</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Cardiac contractility ; Cardiomegaly - genetics ; Cardiomyopathy ; Danon disease ; Disease modeling ; Disease Models, Animal ; Gene Knockout Techniques ; Glycogen Storage Disease Type IIb - genetics ; Glycogen Storage Disease Type IIb - metabolism ; Hypertrophic remodeling ; Lysosomal-Associated Membrane Protein 2 - genetics ; Lysosomal-Associated Membrane Protein 2 - metabolism ; mTOR ; Myocardial Contraction - genetics ; Myocardium - metabolism ; Myofibrils - metabolism ; Phenotype ; Receptors, Adrenergic, beta - metabolism ; Single myofibril ; Stroke Volume ; TOR Serine-Threonine Kinases - antagonists &amp; inhibitors ; TOR Serine-Threonine Kinases - genetics ; TOR Serine-Threonine Kinases - metabolism ; Ventricular Remodeling - genetics ; Zebrafish ; Zebrafish - genetics ; Zebrafish - metabolism</subject><ispartof>Journal of molecular and cellular cardiology, 2019-08, Vol.133, p.199-208</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-a06eb26857f1a4755bee36989642516e2555a27e096919a695a6d7e096436a13</citedby><cites>FETCH-LOGICAL-c459t-a06eb26857f1a4755bee36989642516e2555a27e096919a695a6d7e096436a13</cites><orcidid>0000-0003-4197-7208</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.yjmcc.2019.06.013$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31228518$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dvornikov, Alexey V.</creatorcontrib><creatorcontrib>Wang, Mingmin</creatorcontrib><creatorcontrib>Yang, Jingchun</creatorcontrib><creatorcontrib>Zhu, Ping</creatorcontrib><creatorcontrib>Le, Tai</creatorcontrib><creatorcontrib>Lin, Xueying</creatorcontrib><creatorcontrib>Cao, Hung</creatorcontrib><creatorcontrib>Xu, Xiaolei</creatorcontrib><title>Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy</title><title>Journal of molecular and cellular cardiology</title><addtitle>J Mol Cell Cardiol</addtitle><description>Adult zebrafish is an emerging vertebrate model for studying genetic basis of cardiomyopathies; but whether the simple fish heart can model essential features of hypertrophic cardiomyopathy (HCM) remained unknown. Here, we report a comprehensive phenotyping of a lamp2 knockout (KO) mutant. LAMP2 encodes a lysosomal protein and is a causative gene of Danon disease that is characterized by HCM and massive autophagic vacuoles accumulation in the tissues. There is no effective therapy yet to treat this most lethal cardiomyopathy in the young. First, we did find the autophagic vacuoles accumulation in cardiac tissues from lamp2 KO. Next, through employing a set of emerging phenotyping tools, we revealed heart failure phenotypes in the lamp2 KO mutants, including decreased ventricular ejection fraction, reduced physical exercise capacity, blunted β-adrenergic contractile response, and enlarged atrium. We also noted changes of the following indices suggesting cardiac hypertrophic remodeling in lamp2 KO: a rounded heart shape, increased end-systolic ventricular volume and density of ventricular myocardium, elevated actomyosin activation kinetics together with increased maximal isometric tension at the level of cardiac myofibrils. Lastly, we assessed the function of lysosomal-localized mTOR on the lamp2-associated Danon disease. We found that haploinsufficiency of mtor was able to normalize some characteristics of the lamp2 KO, including ejection fraction, β-adrenergic response, and the actomyosin activation kinetics. In summary, we demonstrate the feasibility of modeling the inherited HCM in the adult zebrafish, which can be used to develop potential therapies. [Display omitted] •Zebrafish has a single LAMP2 homologue.•Loss-of-function of lamp2 in zebrafish models human Danon disease•Both metabolic abnormality and cardiac dysfunction are recapitulated.•mtor inhibition attenuates cardiac dysfunction while metabolic abnormality persists.</description><subject>Animals</subject><subject>Cardiac contractility</subject><subject>Cardiomegaly - genetics</subject><subject>Cardiomyopathy</subject><subject>Danon disease</subject><subject>Disease modeling</subject><subject>Disease Models, Animal</subject><subject>Gene Knockout Techniques</subject><subject>Glycogen Storage Disease Type IIb - genetics</subject><subject>Glycogen Storage Disease Type IIb - metabolism</subject><subject>Hypertrophic remodeling</subject><subject>Lysosomal-Associated Membrane Protein 2 - genetics</subject><subject>Lysosomal-Associated Membrane Protein 2 - metabolism</subject><subject>mTOR</subject><subject>Myocardial Contraction - genetics</subject><subject>Myocardium - metabolism</subject><subject>Myofibrils - metabolism</subject><subject>Phenotype</subject><subject>Receptors, Adrenergic, beta - metabolism</subject><subject>Single myofibril</subject><subject>Stroke Volume</subject><subject>TOR Serine-Threonine Kinases - antagonists &amp; inhibitors</subject><subject>TOR Serine-Threonine Kinases - genetics</subject><subject>TOR Serine-Threonine Kinases - metabolism</subject><subject>Ventricular Remodeling - genetics</subject><subject>Zebrafish</subject><subject>Zebrafish - genetics</subject><subject>Zebrafish - metabolism</subject><issn>0022-2828</issn><issn>1095-8584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9v1DAQxS0EokvhEyAhH7kk2E7sxAeQUMU_qVIR2rs1sSeNlyQOtrdS-ulJu6WCC6fRaN57M5ofIa85Kznj6t2hXA-TtaVgXJdMlYxXT8iOMy2LVrb1U7JjTIhCtKI9Iy9SOjDGdF1Vz8lZxYVoJW935Of3AeeQ18XP1xRmCu44ZnqLXYTep4GOMC2CWojOh2kNC-RhpVNwOFLvcM6-95jotL_6Qf08-M5nH7aURGEzzc47yEjzgBGW9SV51sOY8NVDPSf7z5_2F1-Ly6sv3y4-Xha2ljoXwBR2QrWy6TnUjZQdYqV0q1UtJFcopJQgGmRaaa5BaQnK3bd1pYBX5-TDKXY5dhM6u10ZYTRL9BPE1QTw5t_J7AdzHW6MapisdLMFvH0IiOHXEVM2k08WxxFmDMdkhKilqrlq2k1anaQ2hpQi9o9rODN3lMzB3FMyd5QMU2ajtLne_H3ho-cPlk3w_iTA7U03HqNJ1uNs0fmINhsX_H8X_AaeK6YW</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>Dvornikov, Alexey V.</creator><creator>Wang, Mingmin</creator><creator>Yang, Jingchun</creator><creator>Zhu, Ping</creator><creator>Le, Tai</creator><creator>Lin, Xueying</creator><creator>Cao, Hung</creator><creator>Xu, Xiaolei</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4197-7208</orcidid></search><sort><creationdate>20190801</creationdate><title>Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy</title><author>Dvornikov, Alexey V. ; Wang, Mingmin ; Yang, Jingchun ; Zhu, Ping ; Le, Tai ; Lin, Xueying ; Cao, Hung ; Xu, Xiaolei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-a06eb26857f1a4755bee36989642516e2555a27e096919a695a6d7e096436a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Cardiac contractility</topic><topic>Cardiomegaly - genetics</topic><topic>Cardiomyopathy</topic><topic>Danon disease</topic><topic>Disease modeling</topic><topic>Disease Models, Animal</topic><topic>Gene Knockout Techniques</topic><topic>Glycogen Storage Disease Type IIb - genetics</topic><topic>Glycogen Storage Disease Type IIb - metabolism</topic><topic>Hypertrophic remodeling</topic><topic>Lysosomal-Associated Membrane Protein 2 - genetics</topic><topic>Lysosomal-Associated Membrane Protein 2 - metabolism</topic><topic>mTOR</topic><topic>Myocardial Contraction - genetics</topic><topic>Myocardium - metabolism</topic><topic>Myofibrils - metabolism</topic><topic>Phenotype</topic><topic>Receptors, Adrenergic, beta - metabolism</topic><topic>Single myofibril</topic><topic>Stroke Volume</topic><topic>TOR Serine-Threonine Kinases - antagonists &amp; inhibitors</topic><topic>TOR Serine-Threonine Kinases - genetics</topic><topic>TOR Serine-Threonine Kinases - metabolism</topic><topic>Ventricular Remodeling - genetics</topic><topic>Zebrafish</topic><topic>Zebrafish - genetics</topic><topic>Zebrafish - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dvornikov, Alexey V.</creatorcontrib><creatorcontrib>Wang, Mingmin</creatorcontrib><creatorcontrib>Yang, Jingchun</creatorcontrib><creatorcontrib>Zhu, Ping</creatorcontrib><creatorcontrib>Le, Tai</creatorcontrib><creatorcontrib>Lin, Xueying</creatorcontrib><creatorcontrib>Cao, Hung</creatorcontrib><creatorcontrib>Xu, Xiaolei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of molecular and cellular cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dvornikov, Alexey V.</au><au>Wang, Mingmin</au><au>Yang, Jingchun</au><au>Zhu, Ping</au><au>Le, Tai</au><au>Lin, Xueying</au><au>Cao, Hung</au><au>Xu, Xiaolei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy</atitle><jtitle>Journal of molecular and cellular cardiology</jtitle><addtitle>J Mol Cell Cardiol</addtitle><date>2019-08-01</date><risdate>2019</risdate><volume>133</volume><spage>199</spage><epage>208</epage><pages>199-208</pages><issn>0022-2828</issn><eissn>1095-8584</eissn><abstract>Adult zebrafish is an emerging vertebrate model for studying genetic basis of cardiomyopathies; but whether the simple fish heart can model essential features of hypertrophic cardiomyopathy (HCM) remained unknown. Here, we report a comprehensive phenotyping of a lamp2 knockout (KO) mutant. LAMP2 encodes a lysosomal protein and is a causative gene of Danon disease that is characterized by HCM and massive autophagic vacuoles accumulation in the tissues. There is no effective therapy yet to treat this most lethal cardiomyopathy in the young. First, we did find the autophagic vacuoles accumulation in cardiac tissues from lamp2 KO. Next, through employing a set of emerging phenotyping tools, we revealed heart failure phenotypes in the lamp2 KO mutants, including decreased ventricular ejection fraction, reduced physical exercise capacity, blunted β-adrenergic contractile response, and enlarged atrium. We also noted changes of the following indices suggesting cardiac hypertrophic remodeling in lamp2 KO: a rounded heart shape, increased end-systolic ventricular volume and density of ventricular myocardium, elevated actomyosin activation kinetics together with increased maximal isometric tension at the level of cardiac myofibrils. Lastly, we assessed the function of lysosomal-localized mTOR on the lamp2-associated Danon disease. We found that haploinsufficiency of mtor was able to normalize some characteristics of the lamp2 KO, including ejection fraction, β-adrenergic response, and the actomyosin activation kinetics. In summary, we demonstrate the feasibility of modeling the inherited HCM in the adult zebrafish, which can be used to develop potential therapies. [Display omitted] •Zebrafish has a single LAMP2 homologue.•Loss-of-function of lamp2 in zebrafish models human Danon disease•Both metabolic abnormality and cardiac dysfunction are recapitulated.•mtor inhibition attenuates cardiac dysfunction while metabolic abnormality persists.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31228518</pmid><doi>10.1016/j.yjmcc.2019.06.013</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-4197-7208</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2828
ispartof Journal of molecular and cellular cardiology, 2019-08, Vol.133, p.199-208
issn 0022-2828
1095-8584
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6705397
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Cardiac contractility
Cardiomegaly - genetics
Cardiomyopathy
Danon disease
Disease modeling
Disease Models, Animal
Gene Knockout Techniques
Glycogen Storage Disease Type IIb - genetics
Glycogen Storage Disease Type IIb - metabolism
Hypertrophic remodeling
Lysosomal-Associated Membrane Protein 2 - genetics
Lysosomal-Associated Membrane Protein 2 - metabolism
mTOR
Myocardial Contraction - genetics
Myocardium - metabolism
Myofibrils - metabolism
Phenotype
Receptors, Adrenergic, beta - metabolism
Single myofibril
Stroke Volume
TOR Serine-Threonine Kinases - antagonists & inhibitors
TOR Serine-Threonine Kinases - genetics
TOR Serine-Threonine Kinases - metabolism
Ventricular Remodeling - genetics
Zebrafish
Zebrafish - genetics
Zebrafish - metabolism
title Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T21%3A05%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phenotyping%20an%20adult%20zebrafish%20lamp2%20cardiomyopathy%20model%20identifies%20mTOR%20inhibition%20as%20a%20candidate%20therapy&rft.jtitle=Journal%20of%20molecular%20and%20cellular%20cardiology&rft.au=Dvornikov,%20Alexey%20V.&rft.date=2019-08-01&rft.volume=133&rft.spage=199&rft.epage=208&rft.pages=199-208&rft.issn=0022-2828&rft.eissn=1095-8584&rft_id=info:doi/10.1016/j.yjmcc.2019.06.013&rft_dat=%3Cproquest_pubme%3E2245641678%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2245641678&rft_id=info:pmid/31228518&rft_els_id=S0022282819301348&rfr_iscdi=true